Clark Capital Management Group, Inc. Astrazeneca PLC Call Options Transaction History
Clark Capital Management Group, Inc.
- $13.7 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AZN
# of Institutions
1,448Shares Held
490MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.24 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.37 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.81 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.57 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.55 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $253B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...